Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 140 |
| Receivables | 0 | 0 | 0 | 2 |
| Inventories | 0 | 0 | 0 | 20 |
| Other current assets | 0 | 0 | 0 | -2 |
| TOTAL | $0 | $0 | $0 | $160 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 80 |
| TOTAL | $N/A | $N/A | $N/A | $80 |
| Total Assets | $0 | $0 | $0 | $240 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 0 | 0 | 0 | 360 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 50 |
| Accrued Expenses | 0 | 0 | 0 | 4 |
| TOTAL | $0 | $0 | $0 | $410 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $0 | $0 | $0 | $410 |
| Shareholders' Equity | ||||
| Common Shares | 0 | 0 | 0 | 2 |
| Retained earnings | 0 | 0 | 0 | -690 |
| Other shareholders' equity | 0 | 0 | 0 | 9 |
| TOTAL | $0 | $0 | $0 | $-160 |
| Total Liabilities And Equity | $0 | $0 | $0 | $250 |